Related references
Note: Only part of the references are listed.Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Inhibition of HIF-Ialpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
Lavinia Nardinocchi et al.
MOLECULAR CANCER (2009)
ABCG2 expression and side population abundance regulated by a transforming growth factor β-directed epithelial-mesenchymal transition
Liqun Yin et al.
CANCER RESEARCH (2008)
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2
Chun-ling Dai et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Novel cell culture technique for primary ductal carcinoma in situ: Role of notch and epidermal growth factor receptor signaling pathways
Gillian Farnie et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis
VS Donnenberg et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic
L Patrawala et al.
CANCER RESEARCH (2005)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation
Z Xiao et al.
ONCOGENE (2005)
Stem cells in normal breast development and breast cancer
G Dontu et al.
CELL PROLIFERATION (2003)
Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms
AM Senderowicz
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
